返回
Decoding cancer etiology with cellular reprogramming
DOI:10.1016/j.gde.2024.102301.png)
摘要
En 中文
Cancer research remains clinically unmet in many areas due to limited access to patient samples and the lack of reliable model systems that truly reflect human cancer biology. The emergence of patient-derived induced pluripotent stem cells and engineered human pluripotent stem cells (hPSCs) has helped overcome these challenges, offering a versatile alternative platform for advancing cancer research. These hPSCs are already proving to be valuable models for studying specific cancer driver mutations, offering insights into cancer origins, pathogenesis, tumor heterogeneity, clonal evolution, and facilitating drug discovery and testing. This article reviews recent progress in utilizing hPSCs for clinically relevant cancer models and highlights efforts to deepen our understanding of fundamental cancer biology.
Keyword:
PLURIPOTENT STEM-CELLS
MODEL
期刊
C
IF:
3.6
论文数:
2.9K
被引数:
6.9K
机构
引用论文
Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
CANCER DISCOVERY
IF33.3
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype
NATURE COMMUNICATIONS
IF15.7
Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome
PLOS GENETICS
IF3.7
Second hit impels oncogenesis of retinoblastoma in patient-induced pluripotent stem cell-derived retinal organoids: direct evidence for Knudson's theory
PNAS NEXUS
IF3.8
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia
CELL STEM CELL
IF20.4
Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of GATA1 and STAG2 Mutations in Induced Pluripotent Stem Cells with Trisomy 21
CELLS
IF5.2

